| Catalog No | Product Description | CAS No. | Purity | Structural Formula |
|---|---|---|---|---|
| BP0246 |
Benzoylmesaconine
Benzoylmesaconine is a diterpene alkaloid with formula C31H43NO10 that is isolated from several Aconitum species. It has a role as an antiinfective agent, an analgesic and a plant metabolite. It is a diterpene alkaloid, a tertiary alcohol, a tetrol, a secondary alcohol, a bridged compound, a benzoate ester, an organic heteropolycyclic compound, a polyether and a tertiary amino compound. It derives from a hydride of an aconitane. Benzoylmesconine has analgesic activity. Benzoylmesconine may improve the resistance of T6S-mice (or thermally injured mice) to the infection of HSV-1, through the induction of antagonistic CD4+ T cells against burn-associated type-2 T cells.
|
63238-67-5 | 98% |
|
| BP0216 |
Atractylenolide III
Atractylenolide III, a potential house dust mite control agent, has neuroprotection, gastroprotective, anti-cancer, and anti-inflammatory activities, it also may control immunological reactions by regulating the cellular functions of IL-6 in mast cells. It inhibited nuclear factor-κB and mitogen-activated protein kinase pathways in mouse macrophages, and inhibited Lipopolysaccharide-induced TNF- α and NO production in macrophages. Atractylenolide III is a natural product found in Atractylodes lancea. It has a role as a metabolite.
|
73030-71-4 | 98% |
|
| BP5705 | 1534433-74-3 |
|
||
| BP2041 |
|
|||
| BP0164 |
Andrographolide
Andrographolide is a labdane diterpenoid isolated from the leaves and roots of Andrographis paniculata that exhibits anti-HIV, anti-inflammatory and antineoplastic properties. It has a role as a metabolite, an anti-inflammatory drug, an antineoplastic agent and an anti-HIV agent. It is a primary alcohol, a secondary alcohol, a labdane diterpenoid, a carbobicyclic compound and a gamma-lactone.
Andrographolide is an antiinflammatory, antiviral, anti-cancer , hepatoprotective, antithrombotic, hypotensive and antiatherosclerotic drug, it can cure hyperpigmentation disorders. Andrographolide protects against chemical-induced oxidative damage by up-regulating the gene transcription and activity of antioxidant enzymes in various tissues.Andrographolide has potential as a leading compound in the prevention or treatment of obesity and insulin resistance, can ameliorate lipid metabolism and improve glucose use in mice with HFD-induced obesity.
Andrographolide is an NF - κ B inhibitor that inhibits NF - κ B activation by covalently modifying cysteine residues of p50 in endothelial cells, without affecting I κ B alpha degradation or p50/p65 nuclear translocation. Andrographolide has antiviral effects.
|
5508-58-7 | 98% |
|
| BP4170 | 1937-62-8 |
|
||
| BP4169 | 112-79-8 |
|
||
| BP0159 |
Alpha-Thujone
alpha-thujone is the (1S,4R,5R)-stereoisomer of alpha-thujone. It is an enantiomer of a (+)-alpha-thujone.
|
546-80-5 | 98% |
|
| BP0669 |
Ginsenoside Rh3
Ginsenoside Rh3 is a bacterial metabolite of Ginsenoside Rg5, Rh3 has anti-inflammatory effect in microglia by modulating AMPK and its downstream signaling pathways, it may improve chronic dermatitis or psoriasis by the regulation of IL-1β and TNF-α produced by macrophage cells and of IFN-γ produced by Th cells. Rg5 and Rh3 inhibited acetylcholinesterase activity in a dose-dependent manner, with IC50 values of 18.4 and 10.2 uM, respectively, they may protect memory deficit by inhibiting AChE activity and increasing BDNF expression and CREB activation.
|
105558-26-7 | 95% |
|
| BP2039 |
|
|||
| BP0046 |
20-deoxyingenol
20 Deoxystrobin is a diterpenoid isolated from the roots of Euphorbia kansui. 20 Deoxyingenol can promote autophagy and lysosomal biogenesis by promoting nuclear translocation of transcription factor EB (TFEB) in vitro. 20 Deoxystrobin can be used for research on osteoarthritis (OA).
|
54706-99-9 | 98% |
|
| BP1577 | 921226-01-9 | 98% |
|
|
| SBP04261 | 66056-23-3 |
|
||
| BP1290 |
Sennidin A
Sennidin A, has two hydroxyanthraquinone-like moieties, exerts inhibition on NS3 helicase with IC50 values of 0.8 uM. Sennidin A in combination with necrosis inducing drugs/therapies may generate synergetic tumoricidal effects on solid malignancies by means of primary debulking and secondary cleansing process. It stimulates glucose incorporation in the phosphatidylinositol 3-kinase (PI3K)- and Akt-dependent in rat adipocytes, but in the IR/IRS1-independent manner.
|
641-12-3 | 98% |
|
Shenshuai
Wenjing
Hedandan